Andersons pediatric cardiology 1586

146.CarcellerAM,FouronJC,LetarteJ,etal.
Absenceofmitralvalveprolapseinjuvenile
hyperthyroidism.AmJCardiol.1984;54:455–
456.
147.PilapilVR,WatsonDG.Electrocardiogramin
hyperthyroidchildren.AmJDisChild.
1979;119:245–248.
148.ForfarJC,MuirAL,SawersSA,ToftAD.
Abnormalleftventricularfunctionin
hyperthyroidism.Evidenceforapossible
reversiblecardiomyopathy.NEnglJMed.
1982;307:1165–1170.
149.CavalloA,JosephCJ,CastaA.Cardiac
complicationsinjuvenilehyperthyroidism.AmJ
DisChild.1984;138:479–482.
150.ReddyER.Changesinheartsizeandvolumein
certainendocrinalandnutritionaldeficiency
diseases.Acorrelativestudyintwentyadult
patients.JCanAssocRadiol.1984;35(1):17–19.
151.WillisFR,ByrneGC,JonesTW.Fludrocortisone
inducedheartfailureinAddison'sdisease.J
PaediatrChildHealth.1994;30(3):280–281.
152.Barragan-CamposHM,Barrera-RamirezCF,
IturraldeTorresP,etal.Kearns-sayresyndromes
anabsoluteindicationforprohylactic
implantationofdefinitivepacemaker?ArchInst
CardiolMex.1999;69(6):559–565.


153.SubbiahRN,KucharD,BaronD.Torsadesde
pointesinapatientwithkearns-sayresyndrome:

afortunatefinding.PacingClinElectrophysiol.
2007;30(1):137–139.
154.Marin-GarciaJ,GoldenthalMJ,FilianoJJ.
Cardiomyopathyassociatedwithneurologic
disordersandmitochondrialphenotype.JChild
Neurol.2002;17(10):759–765.
155.RashidA,KimMH.Kearns-sayresyndrome:
associationwithlongQTsyndrome?J
CardiovascElectrophysiol.2002;13(2):184–185.
156.Hernandez-LuisC,Garcia-MoranE,Rubio-Sanz
J,Fernandez-AvilesF.Kearns-sayresyndrome:
recurrentsyncopeandatrialflutter.RevEsp
Cardiol.2007;60(1):89–90.
157.KatsanosKH,PappasCJ,PatsourasD,etal.
Alarmingatrioventricularblockandmitralvalve
prolapseintheKearns-sayresyndrome.IntJ
Cardiol.2002;83(2):179–181.
158.ChallaS,KanikannanMA,MurthyJM,
BhoompallyVR,SurathM.Diagnosisof
mitochondrialdiseases:clinicalandhistological
studyofsixtypatientswithraggedredfibers.
NeurolIndia.2004;52(3):353–358.
159.AgapitosE,PavlopoulosPM,PatsourisE,
DavarisP.Subacutenectrozing
encephalomyelopathy(leigh'sdisease):a


clinicopathologicstudyoftencases.GenDiagn
Pathol.1997;142(5–6):335–341.
160.ClarkeSL,IkonN,RyanRO.Barthsyndrome:

connectingcardiolipintocardiomyopathy.
Lipids.2017;52:99–108.
161.RobertsAE,NixonC,StewardCG,etal.The
barthsyndromeregistry:distinguishingdisease
characteristicsandgrowthdatafroma
longitudinalstudy.AmJMedGenetA.
2012;158A:2726–2732.
162.BradyAN,ShehataBM,FernhoffPM.X-linked
fetalcardiomyopathycausedbyanovel
mutationintheTAZgene.PrenatDiagn.
2006;26:462–465.
163.ClarkeSL,BowronA,GonzalezIL,etal.Barth
syndrome.OrphanetJRareDis.2013;8:23.
164.SpencerCT,ByrneBJ,GeqitzMH,etal.
VentriculararrhythmiaintheX-linked
cardiomyopathybarthsyndrome.Pediatr
Cardiol.2005;26(5):632–637.
165.DesviatLR,ClaveroS,Perez-CerdaC,etal.
Newsplicingmutationsinpropionicacidemia.J
HumGenet.2006;51(11):992–997.
166.MassoudAF,LEanordJV.Cardiomyopathyin
proprionicacidemia.EurJPediatr.
1993;152(5):441–445.
167.BaumgartnerD,Scholl-BurgiS,SassJO,etal.